Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin.

C.M. Zwaan; D Reinhardt; H Jurgens; DR Huismans; K. Hahlen; OP Smith; A Biondi; E.R. van Wering; J Feingold; G.J.L. Kaspers

doi:https://doi.org/10.1038/sj.leu.2402749

Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin.

C.M. Zwaan, D Reinhardt, H Jurgens, DR Huismans, K. Hahlen, OP Smith, A Biondi, E.R. van Wering, J Feingold, G.J.L. Kaspers

VU University medical center

Research output: Contribution to journal › Article › Academic › peer-review

15 Citations (Scopus)

Original language	English
Pages (from-to)	468-70
Journal	Leukemia
Volume	17
Issue number	2
DOIs	https://doi.org/10.1038/sj.leu.2402749
Publication status	Published - 2003

Access to Document

https://doi.org/10.1038/sj.leu.2402749

Cite this

Zwaan, C. M., Reinhardt, D., Jurgens, H., Huismans, DR., Hahlen, K., Smith, OP., Biondi, A., van Wering, E. R., Feingold, J., & Kaspers, G. J. L. (2003). Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin. Leukemia, 17(2), 468-70. https://doi.org/10.1038/sj.leu.2402749

@article{ee73704cbf214e0888e8a8b391a93512,

title = "Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin.",

author = "C.M. Zwaan and D Reinhardt and H Jurgens and DR Huismans and K. Hahlen and OP Smith and A Biondi and {van Wering}, E.R. and J Feingold and G.J.L. Kaspers",

year = "2003",

doi = "https://doi.org/10.1038/sj.leu.2402749",

language = "English",

volume = "17",

pages = "468--70",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "2",

}

Zwaan, CM, Reinhardt, D, Jurgens, H, Huismans, DR, Hahlen, K, Smith, OP, Biondi, A, van Wering, ER, Feingold, J & Kaspers, GJL 2003, 'Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin.', Leukemia, vol. 17, no. 2, pp. 468-70. https://doi.org/10.1038/sj.leu.2402749

TY - JOUR

T1 - Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin.

AU - Zwaan, C.M.

AU - Reinhardt, D

AU - Jurgens, H

AU - Huismans, DR

AU - Hahlen, K.

AU - Smith, OP

AU - Biondi, A

AU - van Wering, E.R.

AU - Feingold, J

AU - Kaspers, G.J.L.

PY - 2003

Y1 - 2003

U2 - https://doi.org/10.1038/sj.leu.2402749

DO - https://doi.org/10.1038/sj.leu.2402749

M3 - Article

SN - 0887-6924

VL - 17

SP - 468

EP - 470

JO - Leukemia

JF - Leukemia

IS - 2

ER -